Form D · Biotechnology
ADVANCED CELL TECHNOLOGY, INC.
Worcester, MA · CIK 0001140098
Offering snapshot reported Dec 7, 2009 · SEC filing
- Reported sold
- $2.78M Offering amount: $2.78M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Nov 12, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2009 | Initial | $2,777,000 | No comparison | 10 | SEC filing |
| Nov 13, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-96793
Includes $1,385,000 of securities sold at the initial closing on November 12, 2009, and November 13, 2009 and $1,385,000 of securities the investors agreed to purchase, subject to customary conditions, within 90 days of initial closing.
Source: Form D, filed Dec 7, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William M. Cladwell | Director, Executive |
| Gary Rabin | Director |
| Erkki Ruoslahti | Director |
| Alan C. Shapiro | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
381 Plantation Street
Worcester, MA, 01605
Worcester, MA, 01605